Similarly, the distinct APOE fractionation patterns across all three experimental cohorts may be indicative of systemic effects, given the role that APOE plays in other neurodegenerative diseases as well as regulation of immune processes and the established role of lipid dysregulation in neurodegeneration [55,56,57]. This evidence concerns the gene APOE and neurodegenerative disease.